SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001837607-24-000059
Filing Date
2024-05-14
Accepted
2024-05-14 09:05:41
Documents
107
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A aeon-20231231x10ka.htm   iXBRL 10-K/A 3137333
2 EX-10.11 aeon-20231231xex10d11.htm EX-10.11 106429
3 EX-23.1 aeon-20231231xex23d1.htm EX-23.1 2858
4 EX-23.2 aeon-20231231xex23d2.htm EX-23.2 2752
5 EX-31.1 aeon-20231231xex31d1.htm EX-31.1 18256
6 EX-31.2 aeon-20231231xex31d2.htm EX-31.2 17565
7 EX-32.1 aeon-20231231xex32d1.htm EX-32.1 8816
8 EX-32.2 aeon-20231231xex32d2.htm EX-32.2 9194
9 EX-97 aeon-20231231xex97.htm EX-97 36183
10 GRAPHIC aeon-20231231x10ka006.jpg GRAPHIC 76091
  Complete submission text file 0001837607-24-000059.txt   13654498

Data Files

Seq Description Document Type Size
11 EX-101.SCH aeon-20231231.xsd EX-101.SCH 110591
12 EX-101.CAL aeon-20231231_cal.xml EX-101.CAL 63361
13 EX-101.DEF aeon-20231231_def.xml EX-101.DEF 492489
14 EX-101.LAB aeon-20231231_lab.xml EX-101.LAB 797937
15 EX-101.PRE aeon-20231231_pre.xml EX-101.PRE 695758
111 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20231231x10ka_htm.xml XML 2183199
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40021 | Film No.: 24941663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)